April 5, 2024

Comparing TEAD Palmitoylation Inhibitors with Differential TEAD Selectivity in Combination Efficacy with Targeted Therapies and in Renal Safety

Research and Publications

The Hippo Pathway and Human Cancer

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

June 28, 2017

Vivace Therapeutics Comes out of Stealth with $40 Million to Turn Novel Biology into First-in-Class Cancer Therapeutics